(Q33499214)

27 July 2017

Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors (English)

1 reference

27 July 2017

1 reference

1 reference

Needle MN

1

1 reference

27 July 2017

Molloy PT

2

1 reference

27 July 2017

Geyer JR

3

1 reference

27 July 2017

Herman-Liu A

4

1 reference

27 July 2017

Belasco JB

5

1 reference

27 July 2017

Goldwein JW

6

1 reference

27 July 2017

Sutton L

7

1 reference

27 July 2017

Phillips PC

8

1 reference

27 July 2017

language of work or name

1 reference

1 July 1997

1 reference

27 July 2017

Pediatric Blood Cancer

1 reference

27 July 2017

29

1 reference

27 July 2017

1

1 reference

27 July 2017

28-32

1 reference

Mechanism of action of antitumor drug etoposide: a review

27 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

Biochemical characteristics and physiological significance of major DNA topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

DNA topoisomerase poisons as antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

Phase I study of oral etoposide in children with refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

Recurrent brainstem gliomas treated with oral VP-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199707%2929%3A1%3C28%3A%3AAID-MPO5%3E3.0.CO%3B2-U

10.1002/(SICI)1096-911X(199707)29:1<28::AID-MPO5>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference